FP

Farhatjahan Parvez Mansuri

Active Director Director DIN 10470549
DIN 10470549 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Farhatjahan Parvez Mansuri

Data last updated:

Farhatjahan Parvez Mansuri is a Director at Plezier Healthcare Private Limited (since 2024). The company operates in Pharma.

DIN 10470549
Primary Designation Director
Industry Pharma
First Appointment 18 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Plezier Healthcare Private Limited U47720GJ2024PTC147856
Director18 Jan 20242024Active

Board colleagues of Farhatjahan Parvez Mansuri

Directorship timeline

Open interactive timeline →
Plezier Healthcare Private Limited
Premium access

Shareholding and investment profile for Farhatjahan Parvez Mansuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Farhatjahan Parvez Mansuri

Farhatjahan Parvez Mansuri currently holds 1 directorship: Plezier Healthcare Private Limited (Director, since 18 Jan 2024).

Farhatjahan Parvez Mansuri was first appointed on 18 Jan 2024 as Director at Plezier Healthcare Private Limited.

The current boards of Farhatjahan Parvez Mansuri's companies include Afifabanu Mohammadhusen Agarbattiwala (Plezier Healthcare Private Limited), Agarbattiwala Jabiullah (Plezier Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available